Definitive Healthcare (DH) Cash & Equivalents (2020 - 2026)

Definitive Healthcare's Cash & Equivalents history runs 7 years deep, the most recent figure standing at $157.6 million for Q1 2026.

• Quarterly Cash & Equivalents rose 48.59% year-over-year to $157.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $157.6 million (up 48.59% YoY) and the FY2025 annual result came in at $163.6 million, up 55.28% from the prior year.
• Cash & Equivalents was $157.6 million for Q1 2026 at Definitive Healthcare, down from $163.6 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $229.8 million in Q1 2022 and bottomed at $77.5 million in Q3 2023.
• A 5-year average of $140.4 million and a median of $131.0 million in 2023 frame the typical range for Cash & Equivalents.
• Annual changes were most pronounced in 2023 — Cash & Equivalents sank 66.15% — and 2024, when it surged 77.65%.
• Definitive Healthcare's Cash & Equivalents stood at $146.9 million in 2022, then slipped by 10.86% to $131.0 million in 2023, then declined by 19.54% to $105.4 million in 2024, then surged by 55.28% to $163.6 million in 2025, then fell by 3.65% to $157.6 million in 2026.
• Business Quant data shows DH's Cash & Equivalents at $157.6 million in Q1 2026, $163.6 million in Q4 2025, and $108.3 million in Q3 2025.